 | | | |
|
|
| FEBS LETTERS
| |
| | |
|
|
 An international journal established for the rapid publication of essentially final short reports in the fields of molecular biosciences.
FEBS Letters and
Molecular Oncology
are published
by Elsevier on behalf of the Federation of European Biochemical Societies
Managing Editor:
Felix Wieland
See editorial board for all editors information
Note for non-subscribers to ScienceDirect: Free access to Special Issues and Mini Reviews is available through  http://www.FEBSLetters.com.
If your institution already subscribes to ScienceDirect, access to Special Issues and Mini Reviews is available through http://www.sciencedirect.com/science/journal/00145793
Description
FEBS Letters is one of the world's leading journals in biochemistry and is renowned both for its quality
of content and speed of production. Bringing together the most important developments in the molecular biosciences, FEBS Letters
provides an international forum for Minireviews, hypotheses and research letters that merit urgent publication.
FEBS Letters
offers:
• Faster publication:
− Accepted articles are published online in 3 days
− The print version
of the article is published in 3 to 5 weeks after acceptance
• Full-text article disclosure in HTML and PDF formats
•
Articles in Press are included in PubMed
• Easy online manuscript submission system
• Transparent online peer review
and manuscript tracking system
• No page charges
• Free color figures
Subject Coverage:
The subject
area of FEBS Letters is broad. It covers biochemistry (including protein chemistry, enzymology, nucleic acid chemistry, metabolism,
and immunochemistry), structural biology, biophysics, computational biology (genomics, proteomics, bioinformatics), molecular genetics,
molecular biology and molecular cell biology (signal transduction, intracellular traffic, regulation of cellular proliferation, cell-cell
interactions) and systems biology. Studies on microbes, plants and animals at the molecular level are within the scope of FEBS
Letters.
Submitting Authors:
Manuscripts can be submitted to FEBS Letters at: http://ees.elsevier.com/febsletters/
Bibliographic & ordering information
ISSN: 0014-5793
Imprint: ELSEVIER
Commenced publication 1968
Subscriptions for the year 2008,
Volume 582,
30 issues
Institutional online access: ScienceDirect eSelect
For purchase of online access to this journal on ScienceDirect.
Personal price: Order form
EUR 646 for European countries and Iran
JPY 94,000 for Japan
USD 814 for all countries except Europe, Japan and Iran
Institutional price: Order form
USD 5,393 for all countries except Europe, Japan and Iran
EUR 4,821 for European countries and Iran
JPY 688,200 for Japan
Conditions of sale & ordering procedures, and links to our regional sales offices.
For an overview of recently-dispatched issues, see the Journal issue
dispatch dates
Audience
Biochemists, biophysicists, cell and molecular biologists.
Sponsored Articles:
FEBS Letters offers authors
the option to sponsor non-subscriber access to their articles on Elsevier's electronic publishing platforms. For more information please
view our Sponsored Article page.
Impact factor of this journal
2007: 3.263
© Journal Citation Reports 2008, published by Thomson Reuters
602/177
Last update: 4 Jul 2008
|
|
| |
| | |
|
|
| |
|
